BRPI0507404A - método de tratamento de um indivìduo que tem psorìase e kit - Google Patents

método de tratamento de um indivìduo que tem psorìase e kit

Info

Publication number
BRPI0507404A
BRPI0507404A BRPI0507404-5A BRPI0507404A BRPI0507404A BR PI0507404 A BRPI0507404 A BR PI0507404A BR PI0507404 A BRPI0507404 A BR PI0507404A BR PI0507404 A BRPI0507404 A BR PI0507404A
Authority
BR
Brazil
Prior art keywords
psoriasis
individual
kit
treating
treatment
Prior art date
Application number
BRPI0507404-5A
Other languages
English (en)
Inventor
Daniel Magilavy
Original Assignee
Astellas Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Us Llc filed Critical Astellas Us Llc
Publication of BRPI0507404A publication Critical patent/BRPI0507404A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70528—CD58
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

MéTODO DE TRATAMENTO DE UM INDIVIDUO QUE TEM PSORIASE E KIT Método de tratamento de distúbios da pele são proporcionados.
BRPI0507404-5A 2004-02-06 2005-02-07 método de tratamento de um indivìduo que tem psorìase e kit BRPI0507404A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54231104P 2004-02-06 2004-02-06
PCT/US2005/003907 WO2005077018A2 (en) 2004-02-06 2005-02-07 Methods of treating skin disorders

Publications (1)

Publication Number Publication Date
BRPI0507404A true BRPI0507404A (pt) 2007-06-26

Family

ID=34860280

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507404-5A BRPI0507404A (pt) 2004-02-06 2005-02-07 método de tratamento de um indivìduo que tem psorìase e kit

Country Status (7)

Country Link
US (1) US20070172478A1 (pt)
EP (1) EP1718329A4 (pt)
CN (1) CN1953766A (pt)
BR (1) BRPI0507404A (pt)
CA (1) CA2555144A1 (pt)
MX (1) MXPA06008918A (pt)
WO (1) WO2005077018A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008020575A (ja) * 2006-07-12 2008-01-31 Ricoh Co Ltd 定着装置、画像形成装置
CN101113459A (zh) * 2007-07-16 2008-01-30 东莞太力生物工程有限公司 一种重组复制缺陷型病毒、含有该病毒的药物组合物及其应用
HUE040205T2 (hu) * 2010-07-13 2019-02-28 Georgia State Univ Research Foundation Anti-angiogén szer, és egy ilyen szer alkalmazási módja

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579844A (en) * 1976-05-13 1986-04-01 Johnson & Johnson Topical anti-inflammatory drug therapy
EP0091539B2 (en) * 1982-03-31 1996-11-27 Ajinomoto Co., Inc. Gene coding for interleukin-2 polypeptide, recombinant DNA carrying said gene, cell lines possessing the recombinant DNA,and method for producing interleukin-2 using said cells
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4681760A (en) * 1985-04-17 1987-07-21 The Board Of Trustees Of The Leland Stanford Junior University Method of conferring immunotolerance to a specific antigen
NZ215865A (en) * 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
US5047336A (en) * 1985-10-30 1991-09-10 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing mullerian inhibiting substance-like polypeptides
JPH0763830B2 (ja) * 1985-11-26 1995-07-12 アスモ株式会社 ダイカスト鋳造金型への離型剤塗布方法
US5190859A (en) * 1987-02-26 1993-03-02 Dana-Farber Cancer Institute, Inc. Purification of LFA-3
US4956281A (en) * 1987-06-03 1990-09-11 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing lymphocyte function associated antigen-3
US5336603A (en) * 1987-10-02 1994-08-09 Genentech, Inc. CD4 adheson variants
US5185441A (en) * 1988-08-26 1993-02-09 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US5225538A (en) * 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US5122514A (en) * 1990-04-23 1992-06-16 Abbott Laboratories Psoriasis treatment
CA2081028C (en) * 1991-03-12 1999-12-14 Barbara P. Wallner Cd2 binding domain of lymphocyte function associated antigen 3
MX9203138A (es) * 1991-03-12 1992-09-01 Biogen Inc Dominio de enlace cd2-de antigeno 3 (lfa-3) asociado con funcion linfositos.
AU660312B2 (en) * 1991-06-06 1995-06-22 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha LFA-3-like protein, derivatives thereof, genes thereof and processes for preparing the same
US6162432A (en) * 1991-10-07 2000-12-19 Biogen, Inc. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
US6764681B2 (en) * 1991-10-07 2004-07-20 Biogen, Inc. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
US6270766B1 (en) * 1992-10-08 2001-08-07 The Kennedy Institute Of Rheumatology Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
US5951983A (en) * 1993-03-05 1999-09-14 Universite Catholique De Louvain Methods of inhibiting T cell mediated immune responses with humanized LO-CD2A-specific antibodies
US5817311A (en) * 1993-03-05 1998-10-06 Universite Catholique De Louvain Methods of inhibiting T-cell medicated immune responses with LO-CD2a-specific antibodies
US5730979A (en) * 1993-03-05 1998-03-24 Universite Catholique Delouvain LO-CD2a antibody and uses thereof for inhibiting T cell activation and proliferation
US5795572A (en) * 1993-05-25 1998-08-18 Bristol-Myers Squibb Company Monoclonal antibodies and FV specific for CD2 antigen
BR9607492A (pt) * 1995-01-16 1999-06-29 Commw Scient Ind Res Org Conjugados de ácidos graxos de composto terapêutico
MXPA01002111A (es) * 1998-08-31 2003-03-27 Biogen Inc Metodo para modular celulas t efectoras de memoria y composiciones.
US6337337B1 (en) * 1998-09-03 2002-01-08 Carol J. Buck Methods for treating disorders responsive to DHFR-inhibition
US20020009466A1 (en) * 1999-08-31 2002-01-24 David J. Brayden Oral vaccine compositions
SK9722003A3 (en) * 2001-02-01 2004-05-04 Biogen Inc Methods for treating or preventing skin disorders using CD2-binding agents
AU2002250236A1 (en) * 2001-03-02 2002-09-19 Medimmune, Inc. Cd2 antagonists for treatment of autoimmune or inflammatory disease

Also Published As

Publication number Publication date
CA2555144A1 (en) 2005-08-25
MXPA06008918A (es) 2007-03-07
CN1953766A (zh) 2007-04-25
WO2005077018A2 (en) 2005-08-25
WO2005077018A3 (en) 2005-12-08
US20070172478A1 (en) 2007-07-26
EP1718329A4 (en) 2008-09-10
EP1718329A2 (en) 2006-11-08

Similar Documents

Publication Publication Date Title
ATE540129T1 (de) Target zur therapie kognitiver behinderungen
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
BRPI0408476A (pt) métodos para melhorar a qualidade da pele
TW200612918A (en) Lonidamine analogs
NO20070561L (no) Sammensetninger og fremgangsmater for a behandle oyesykdommer og tilstander.
BRPI0309665B8 (pt) método para analisar uma preparação de alfagalactosidase a
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
ATE544748T1 (de) Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen
BRPI0810336A2 (pt) "método para tratar e/ou prevenir úlceras de pele em um indivíduo"
DE50312289D1 (de) Verfahren zur Isolierung von mesenchymalen Stammzellen des Haarfollikels
EA200901555A1 (ru) Композиция местного применения по уходу за кожей и способ лечения
IL189019A0 (en) Pdt (photodynamic therapy) treatment method for cellulites and cosmetic use
CY1119317T1 (el) Συνθεση για τοπικη εφαρμογη, χρησεις αυτης, συσκευη εφαρμογης και kit μερων
MX349188B (es) Sns - 595 y metodos para utilizar el mismo.
TR201818983T4 (tr) İnflamatuvar Cilt Bozukluklarının Tedavisine Yönelik Olarak Sübstitüe Edilmiş Tetrasiklin Bileşikleri
DE602004022285D1 (de) Verfahren zur behandlung von erkrankungen mit hsp90-hemmenden mitteln in kombination mit antimitotika
MX2007010484A (es) Moleculas y metodos para usarlas para tratar enfermedades asociadas con mcp-1/ccr2.
ATE442861T1 (de) Gegen antikörper gerichtete photodynamische therapie
MX2021009684A (es) Composicion cosmetica.
DE60237039D1 (de) Verfahren zur behandlung von rosacea und telangiectasia
BR0312696A (pt) Tratamento tópico de doenças da pele
TW200605885A (en) Multicyclic lonidamine analogs
BRPI0507404A (pt) método de tratamento de um indivìduo que tem psorìase e kit
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
BRPI0507302A (pt) método e composições para o tratamento da lipodistrofia

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.